Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00084110 · ClinicalTrials.gov registry record
Use of Complementary and Alternative Medicine Among Older Mexican Americans
A clinical trial, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Terminated
- Registry status
- 3,000
- Enrollment target
NCT00084110: Clinical Trial study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00084110 is a clinical trial that was terminated before completion, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00084110 was terminated before completion, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- TERMINATED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The purpose of this study is to examine complementary and alternative medicine use among older Mexican Americans and to determine how this use influences physical, functional, and mental health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 1993-08 |
| Est. Completion | 2000-09 |
Why NCT00084110 stopped before completion
NCT00084110 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00084110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00084110 about?
NCT00084110 is a clinical study titled "Use of Complementary and Alternative Medicine Among Older Mexican Americans". The purpose of this study is to examine complementary and alternative medicine use among older Mexican Americans and to determine how this use influences physical, functional, and mental health.
What is the current status of trial NCT00084110?
This trial is currently terminated. The enrollment target is 3,000 participants. The study started on 1993-08. Estimated completion is 2000-09.
Who is sponsoring clinical trial NCT00084110?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia